Trial intelligence / Profile preview

Paclitaxel and Carboplatin in Uterine Carcinosarcoma

NCT00112489Phase 2Completed

Sponsor
GOG Foundation
Start
May 2005
Primary completion
Jul 2010
Modality
DNA Intercalators/Alkylators
Countries
2
01

Overview

A Phase 2 trial of paclitaxel, carboplatin in uterine carcinosarcoma (UCS), sponsored by GOG Foundation. Started May 2005; status: completed.

02

Drugs

paclitaxelcarboplatin
03

Conditions

uterine carcinosarcoma (UCS)

Beyond the preview

Go deeper on NCT00112489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00112489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call